CalRx aims to be another competitor in the field by introducing a lower-cost alternative \u2014 and possibly put \u201cpressure on other manufacturers to lower their prices<\/a> as well.\u201d<\/p>\n According to the state and Civica<\/a>, the suggested retail price is:<\/p>\n According to the HCAI spokesperson in an email to KQED, the \u201cout-of-pocket cost may be lower, depending on insurance coverage.\u201d<\/p>\n Advocates for people with diabetes see the production as a win.<\/p>\n \u201cWe look forward to the rollout of CalRx\u00ae insulin in January,\u201d said Christine Fallabel, director of state government affairs at the American Diabetes Association, in an email to KQED. \u201cAny meaningful step to improve insulin affordability and provide additional options is a win for people with diabetes.\u201d<\/p>\n Fallabel also pointed to the recent passage of Senate Bill 40<\/a> \u2014 which prohibits high copayments for a month\u2019s supply of insulin \u2014 as another state decision that helps with accessibility.<\/p>\n According to the HCAI spokesperson, \u201cCalRx and Civica cannot mandate the final price to the consumer as this would conflict with antitrust and competition law.\u201d<\/p>\n But the spokesperson stated in the email that Civica is planning to include a QR code on the side of the boxes, so consumers can report if they have paid more than $55 for the product.<\/p>\n \u201cAt which point Civica would contact the pharmacy for remediation,\u201d the spokesperson said.<\/p>\n You do not need to apply<\/a> to access the new insulin, and there are no eligibility requirements. You do not need insurance<\/a>.<\/p>\n \u201cBroad wholesale distribution will allow any California pharmacy to order CalRx insulin glargine,\u201d the state explained in the email. Mail-order pharmacy outreach is still ongoing.<\/p>\n People interested in the CalRx insulin can \u201cask their pharmacist or doctor if they can switch their prescription to CalRx insulin glargine,\u201d continued the HCAI spokesperson. Since the CalRx insulin is interchangeable with other brand names, you would not need a new doctor\u2019s prescription<\/a>.<\/p>\n \u201cHealth plans will be responsible for communicating about CalRx insulin glargine with their provider and patient networks,\u201d HCAI said.<\/p>\n According to the HCAI spokesperson, \u201cYes, Civica Rx\u2019s glargine insulin will be available in other states under Civica Rx\u2019s label<\/a>.\u201d<\/p>\n Where can I learn more information?<\/p>\n KQED\u2019s April Dembosky<\/a> contributed to this report<\/em>.<\/p>\n<\/div>\n\n
![\"\"](\"https:\/\/cdn.kqed.org\/wp-content\/uploads\/sites\/10\/2026\/01\/GavinNewsomInsulinAP.jpg\")
What should I do if I am paying more than $55?<\/h2>\n
Where can I get CalRx insulin? Do I need a prescription?<\/h2>\n
Can people in other states access it?<\/h2>\n